Published on
September 17, 2025
- 22:07 GMT
OWP Pharmaceuticals Announces FDA Approval of SUBVENITE® Oral Suspension
The First and Only Lamotrigine Oral Suspension in the U.S. LISLE, IL, UNITED STATES, September 17, 2025 /EINPresswire.com/ -- OWP Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved SUBVENITE® Oral Suspension, …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
